Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease

Liver International : Official Journal of the International Association for the Study of the Liver
Jane I GroveGuruprasad P Aithal

Abstract

Chronic liver disease presents a major global public health challenge. Stratification of asymptomatic, at-risk patients in primary care using non-invasive methods has the potential to address this by identifying those likely to progress. We, therefore, evaluated variant alleles at loci associated with non-alcoholic fatty liver disease as genetic determinants of substantial liver injury in patients with disease risk factors. Levels of serum procollagen III (PIIINP), an established fibrosis and steatohepatitis marker, were determined in 467 people who had type 2 diabetes and/or BMI > 27.3 (identified from registration with general practitioners) in this observational cross-sectional study. Patients were genotyped for characterised risk alleles in PNPLA3 (rs738409), GCKR (rs1260326) and TM6SF2 (rs58542926) and associations with PIIINP assessed. The risk alleles in PNPLA3, GCKR or TM6SF2 were not found to be individually associated with the presence of a disease risk factor and were not significantly more common in patients with raised serum PIIINP. The prevalence of possession of both PNPLA3 and GCKR variant alleles combined was significantly higher in at-risk patients with clinically significant liver disease indicated by serum P...Continue Reading

References

Jun 16, 2009·Gastroenterology·Anna KotronenHannele Yki-Järvinen
Oct 22, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S RomeoM G Baroni
Apr 8, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca ValentiChristopher P Day
Jul 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elizabeth K SpeliotesJoel N Hirschhorn
Aug 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yaron RotmanUNKNOWN NASH CRN
Sep 11, 2010·BMC Gastroenterology·Mireen Friedrich-RustChristoph Sarrazin
Mar 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvia Sookoian, Carlos J Pirola
Aug 30, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sudeep TanwarWilliam M Rosenberg
Feb 12, 2013·BMJ : British Medical Journal·Neeraj BhalaJames Ferguson
Aug 2, 2013·The New England Journal of Medicine·Christopher J L Murray, Alan D Lopez
Dec 18, 2013·Journal of Hepatology·Jenni HyysaloHannele Yki-Järvinen
Nov 8, 2014·Journal of Lipid Research·Jian-Hua ShenYu-Hong Huang
Jul 7, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Jin-Ho ParkSek Won Kong
Aug 15, 2015·BioMed Research International·Paola DongiovanniLuca Valenti
Aug 25, 2015·Gastroenterology·Rohit LoombaUNKNOWN Genetics of NAFLD in Twins Consortium
Oct 4, 2015·Nature·UNKNOWN 1000 Genomes Project ConsortiumGonçalo R Abecasis
Oct 27, 2015·Current Hepatology Reports·Ahilan Arulanandan, Rohit Loomba
Nov 5, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·L TanajewskiR A Elliott
Dec 18, 2015·Seminars in Liver Disease·Bratati KahaliElizabeth K Speliotes
Feb 14, 2016·Gastroenterology·Quentin M AnsteeChristopher P Day
Apr 4, 2016·Journal of Hepatology·Eric TrépoPierre Nahon
Apr 30, 2016·International Journal of Molecular Sciences·Elina M Petäjä, Hannele Yki-Järvinen
Apr 25, 2017·Nature Genetics·Stefan StenderJonathan C Cohen

❮ Previous
Next ❯

Citations

Dec 19, 2019·Alimentary Pharmacology & Therapeutics·Guruprasad P Aithal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.